cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results

health news

Charlotte, North Carolina–(Newsfile Corp. – August 12, 2025) – cbdMD, Inc. (NYSE American: YCBD), one of the nation’s leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company’s June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.

CONFERENCE CALL DETAILS

Thursday, August 14, 2025, 4:20 p.m. Eastern Time  
   
USA/Canada:  833-821-3524
   
International:  647-846-2919
   
   
Teleconference Replay dial in:  
   
USA/Canada:  855-669-9658
   
International:  412-317-0088
   
Replay Passcode:  5327882
   
Webcast/Webcast Replay link – available through August 15, 2026  
https://www.gowebcasting.com/14151  

 

About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD’s products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.

Contact Information:

cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/262184

Iframe sync
error: Content is protected !!